[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Page 21890]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08270]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-609]


Importer of Controlled Substances Application: Purisys, LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 20, 2020. 
Such persons may also file a written request for a hearing on the 
application on or before May 20, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on January 30, 2020, Purisys, LLC, 1550 Olympic Drive, 
Athens, Georgia 30601-1602 applied to be registered as an importer of 
the following basic class(es) of controlled substances:

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Marihuana Extract......................    7350  I
Marihuana..............................    7360  I
Tetrahydrocannabinols..................    7370  I
Nabilone...............................    7379  II
Phenylacetone..........................    8501  II
Levorphanol............................    9220  II
Thebaine...............................    9333  II
Poppy Straw Concentrate................    9670  II
Tapentadol.............................    9780  II
------------------------------------------------------------------------

    The company plans to import drug code 8501, Phenylacetone and drug 
code 9670, Poppy Straw Concentrate to bulk manufacture other controlled 
substances for distribution to its customers. The company plans to 
import impurities of buprenorphine that have been determined by DEA to 
be captured under drug code 9333, Thebaine. In reference to drug codes 
7360, Marihuana and 7370, Tetrahydrocannabinols the company plans to 
import a Synthetic Cannabidiol and a Synthetic Tetrahydrocannabinol. No 
other activity for these drug codes is authorized for this 
registration. Placement of these drugs codes on the company's 
registration does not translate into automatic approval of subsequent 
permit applications to import controlled substances. Approval of permit 
applications will occur only when the registrant's business activity is 
consistent with what is authorized under 21 U.S.C. 952(a)(2). 
Authorization will not extend to the import of FDA-approved or non-
approved finished dosage forms for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08270 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P